1.Primary Tuberculosis of the Cheek: A Common Disease with a Rare Presentation
Neena Chaudhary ; Deepak K Gupta ; Santosha Ram Choudhary ; Leelavathi Dawson
Malaysian Journal of Medical Sciences 2014;21(1):66-68
Tuberculosis of the extra-oral region is uncommon and is rarely primary. Extra-oral involvement of the cheek in the absence of tuberculosis elsewhere in the body is rare. To the best of our knowledge, we report here the first case of primary tuberculosis of the cheek in a 31-year-old male presenting as a nodular swelling of the cheek. Previous reported cases of extra-oral involvement of the cheek involved either fistula or sinus of the cheek. Excisional biopsy for tissue diagnosis and bacterial examination with culture should be performed for an early diagnosis as a delay in treatment can lead to devastating consequences.
Tuberculosis
;
Cheek
2.Herniation of malignant lung cavity.
Saurabh Kumar SINGH ; Rakesh BHARGAVA ; Zuber AHMAD ; Deepak K PANDEY ; Shirin NAAZ ; Vibhanshu GUPTA
Chinese Medical Journal 2008;121(17):1757-1758
Adenocarcinoma
;
complications
;
Female
;
Hernia
;
etiology
;
Humans
;
Lung Diseases
;
etiology
;
Lung Neoplasms
;
complications
;
Middle Aged
3.Clinical behaviour and outcome in pediatric glioblastoma: current scenario
Aditya Kumar SINGLA ; Renu MADAN ; Kirti GUPTA ; Shikha GOYAL ; Narendra KUMAR ; Sushant Kumar SAHOO ; Deepak K. UPPAL ; Chirag K. AHUJA
Radiation Oncology Journal 2021;39(1):72-77
Pediatric glioblastoma (pGBM) is a rare entity accounting for only approximately 3% of all childhood brain tumors. Treatment guidelines for pGBM have been extrapolated from those in adult glioblastoma. Rarity of pGBM and underrepresentation of pediatric population in major studies precludes from defining the ideal treatment protocol for these patients. Maximum safe resection is performed in most of the cases followed by postoperative radiotherapy in children over 3 years of age. Benefit of temozolomide is unclear in these patients. Here, we present the clinicopathological details and outcome of six pGBM patients treated at our institute in 2018–2019.
4.Clinical behaviour and outcome in pediatric glioblastoma: current scenario
Aditya Kumar SINGLA ; Renu MADAN ; Kirti GUPTA ; Shikha GOYAL ; Narendra KUMAR ; Sushant Kumar SAHOO ; Deepak K. UPPAL ; Chirag K. AHUJA
Radiation Oncology Journal 2021;39(1):72-77
Pediatric glioblastoma (pGBM) is a rare entity accounting for only approximately 3% of all childhood brain tumors. Treatment guidelines for pGBM have been extrapolated from those in adult glioblastoma. Rarity of pGBM and underrepresentation of pediatric population in major studies precludes from defining the ideal treatment protocol for these patients. Maximum safe resection is performed in most of the cases followed by postoperative radiotherapy in children over 3 years of age. Benefit of temozolomide is unclear in these patients. Here, we present the clinicopathological details and outcome of six pGBM patients treated at our institute in 2018–2019.